Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Transgenic replacement of Cx32 in gap junction deficient oligodendrocytes rescues the phenotype of a hypomyelinating leukodystrophy model.
Assessing relapse in multiple sclerosis questionnaire: results of a pilot study.
Cytoplasmic sphingosine-1-phosphate pathway modulates neuronal autophagy.
The Clinical Characteristics of Primary Sjogren's Syndrome With Neuromyelitis Optica Spectrum Disorder in China: A STROBE-Compliant Article.
Metabotropic glutamate receptor 5 modulates calcium oscillation and innate immune response induced by lipopolysaccharide in microglial cell.
Cytometric profiling in various clinical forms of multiple sclerosis with respect to CD21+, CD32+, and CD35+ B and T cells.
[LINGO-1 Expression of brain tissue in Experimental Autoimmune Encephalomyelitis Mouse].
First-dose effects of fingolimod: Pooled safety data from three phase 3 studies.
FLT PET/CT in a Case of Demyelinating Disease.
Role of socio-economic and reproductive factors in the risk of multiple sclerosis.
Application of next-generation sequencing technologies in Neurology.
Parasite Infections in Multiple Sclerosis Modulate Immune Responses through a Retinoic Acid-Dependent Pathway.
An exploration of impaired walking dynamics and fatigue in Multiple Sclerosis.
Effect of a self-management and follow-up program on self-efficacy in patients with multiple sclerosis: a randomized clinical trial.
Status epilepticus associated with dalfampridine in a patient with multiple sclerosis.
Optic nerve head component responses of the multifocal electroretinogram in MS.
Validity of The Timed Up and Go as A Measure of Functional Mobility in Persons with Multiple Sclerosis.
Perspectives on cytokine-directed therapies in multiple sclerosis.
[Low back pain: atypical presentation of multiple sclerosis.]
Investigating the phenomenon of "cognitive-motor interference" in multiple sclerosis by means of dual-task posturography.
Therapeutic advances in tremor.
Cost effectiveness of Sativex for spasticity in multiple sclerosis.
Is there a cognitive signature for MS-related fatigue?
Concentration of 25(OH)D3 and calcium and phosphorus metabolism in patients suffering from relapsing-remitting multiple sclerosis. A pilot study.
B cells in MS and NMO: pathogenesis and therapy.
Pages
« first
‹ previous
…
509
510
511
512
513
514
515
516
517
…
next ›
last »